Search for: "BM" Results 201 - 220 of 430
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Jan 2011, 10:00 pm by Rosalind English
BM appealed, grouping its grounds of appeal under  substantive and procedural grounds. [read post]
6 Oct 2008, 12:00 pm
Maurice Lopez, Managing Director, Citigroup Global Markets - Patrick Schultheis, Partner, Wilson Sonsini Goodrich & Rosati - Bill Schreier, Head of Equity Capital Markets, BM Capital Markets Coming Soon? [read post]
27 Oct 2010, 5:45 pm by Larry Jones
"  In the agency's warning letter to BMS, the FDA told the company that "it could hold up approval of new products if the deficiencies are not corrected quickly. [read post]
3 Jan 2007, 12:20 pm
He now seeks to rectify that omission:December 2006Alex Weedon on material transfer agreementsPt 2 of IPKat co-bm Ilanah's article on the introduction of performers' moral rightsNicholas Briggs on patent entitlementPt 1 of Thomas Hays' article on secondary copyright liabilityLee-Ann Tong on South African computer program copyrightHerman Cohen Jehoram on Dutch perfume copyrightJanuary 2007 Thomas Riis and Jens Schovsbo on copyright and users John Hull on academic… [read post]
22 Dec 2008, 1:00 pm
Drug-eluting stents in current clinical use were approved by the FDA after clinical trials showed they were statistically superior to bare-metal stents (BMS) for the treatment of native coronary artery narrowings, having lower rates of major adverse cardiac events (MACE) (usually defined as a composite clinical endpoint of death + myocardial infarction + repeat intervention because of restenosis)   [read post]
22 Oct 2013, 2:28 pm by Robert Vrana
” Judge Stark agreed with BMS and explained that “[t]o the extent the Court’s holding involves a clarification of its prior claim construction, such clarification is permissible. [read post]
29 Dec 2009, 9:09 pm by ipdeals
Donabedian, PhD, MBA, Vice President, Strategic Alliances, US CEEDD, GSK Laura Pierce, Vice President, Alliance Management, Bayer HealthCare Pharmaceuticals Graham Brazier, VP, Therapeutic and Commercial Transactions, BMS Mark A. [read post]
29 Dec 2009, 9:09 pm by ipdeals
Donabedian, PhD, MBA, Vice President, Strategic Alliances, US CEEDD, GSK Laura Pierce, Vice President, Alliance Management, Bayer HealthCare Pharmaceuticals Graham Brazier, VP, Therapeutic and Commercial Transactions, BMS Mark A. [read post]
2 Nov 2006, 9:50 pm
  With respect to irreparable harm, Apotex argued that by agreeing to limit damages to 50% of Apotex's sales of generic Plavix, Sanofi and BMS essentially admitted their damages could be calculated and therefore there is an adequate remedy at law, precluding an injunction. [read post]
1 May 2014, 1:29 am by Ben Vernia
(One previously filed qui tam had alleged that BMS paid kickbacks – like the relator’s complaint – but the relator had withdrawn those allegations.) [read post]
16 Jun 2011, 12:15 pm by Jeralyn
TalkLeft turned 9 years old yesterday. [read post]
15 Sep 2011, 12:00 am
Dallas “Mini-Conference” Explores Big Electronic Discovery Issues – Future Still Blurry Facebook launches improved Friends list section [read post]
7 Nov 2014, 8:40 am
For some companies, there is a buyer out there, somewhere, but for the fact that the identity of that interested party is unknown. [read post]
10 May 2012, 10:50 am
As part of our search for spinal cord injury information, a source has learned that these types of injuries are fairly common in parts of Nevada. [read post]
7 Jun 2012, 9:05 pm
The Michigan No-Fault law provides in pertinent part: An insurer providing personal protection insurance benefits shall offer, at appropriately reduced premium rates, deductibles and exclusions, reasonably related to other health and accident coverage on the insured. [read post]